SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-021463
Filing Date
2023-03-20
Accepted
2023-03-20 17:14:56
Documents
16
Period of Report
2023-03-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea175532-8k_allarity.htm   iXBRL 8-K 35947
2 SECOND CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION ea175532-8kex3i_allarity.htm EX-3.1 1509
6 GRAPHIC ex3i_1.jpg GRAPHIC 70244
7 GRAPHIC ex3i_2.jpg GRAPHIC 183896
8 GRAPHIC ex3i_3.jpg GRAPHIC 39818
  Complete submission text file 0001213900-23-021463.txt   626157

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE allr-20230320.xsd EX-101.SCH 3272
4 XBRL LABEL FILE allr-20230320_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE allr-20230320_pre.xml EX-101.PRE 22819
10 EXTRACTED XBRL INSTANCE DOCUMENT ea175532-8k_allarity_htm.xml XML 3989
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 23747111
SIC: 2834 Pharmaceutical Preparations